Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer

  • Magdalena Zajac1,
  • Gonzalo Gomez2,
  • Javier Benitez1, 3 and
  • Beatriz Martínez-Delgado1, 3Email author
BMC Medical Genomics20103:44

DOI: 10.1186/1755-8794-3-44

Received: 11 May 2010

Accepted: 4 October 2010

Published: 4 October 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 May 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 May 2010 Author responded Author comments - Magdalena Zajac
Resubmission - Version 3
12 May 2010 Submitted Manuscript version 3
9 Jul 2010 Reviewed Reviewer Report - Chia-Huey Ooi
17 Jul 2010 Reviewed Reviewer Report - Seiichi Mori
30 Jul 2010 Author responded Author comments - Magdalena Zajac
Resubmission - Version 4
30 Jul 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
10 Aug 2010 Reviewed Reviewer Report - Chia-Huey Ooi
30 Aug 2010 Author responded Author comments - Magdalena Zajac
Resubmission - Version 6
30 Aug 2010 Submitted Manuscript version 6
29 Sep 2010 Author responded Author comments - Magdalena Zajac
Resubmission - Version 7
29 Sep 2010 Submitted Manuscript version 7
Publishing
4 Oct 2010 Editorially accepted
4 Oct 2010 Article published 10.1186/1755-8794-3-44

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Human Genetics Group, Spanish National Cancer Centre (CNIO)
(2)
Bioinformatics Unit. CNIO
(3)
CIBERER, Centre for Biomedical Networking Research on Rare diseases

Advertisement